v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash flows from operating activities    
Net loss $ (13,909) $ (26,908)
Adjustments to reconcile net loss to net cash used in operating activities    
Depreciation and amortization expense 222 221
Change in fair value - Senior Secured Convertible Note 1,859 14,478
Amortization of common stock payment for vendor service agreement 29 74
Changes in operating assets and liabilities:    
Accounts receivable (46) (16)
Prepaid expenses and other current assets (1,247) (185)
Accounts payable 108 (412)
Accrued expenses and other current liabilities (519) (756)
Net cash flows used in operating activities (12,101) (12,465)
Cash flows from investing activities    
Purchase of equipment (215) (93)
Net cash flows used in investing activities (215) (93)
Cash flows from financing activities    
Proceeds – issue of Senior Secured Convertible Notes 0 360
Tax withholdings on equity based compensation (17) 0
Proceeds – exercise of stock options 20 3
Proceeds – issue common stock – Employee Stock Purchase Plan 210 141
Net cash flows provided by financing activities 5,487 15,438
Net (decrease) increase in cash (6,829) 2,880
Cash, beginning of period 34,705 22,358
Cash, end of period 27,876 25,238
Registered Direct Offering [Member]    
Cash flows from financing activities    
Proceeds – issue of common stock 0 14,934
At-the-market Offering [Member]    
Cash flows from financing activities    
Proceeds – issue of common stock 5,274 0
PAVmed [Member]    
Changes in operating assets and liabilities:    
Due To: PAVmed Inc. - operating expenses, employee related costs, MSA Fee (9) 9
Lucid Diagnostics 2018 Equity Plan [Member]    
Adjustments to reconcile net loss to net cash used in operating activities    
Stock-based compensation 1,402 949
PAVmed 2014 Equity Plan [Member]    
Adjustments to reconcile net loss to net cash used in operating activities    
Stock-based compensation $ 9 $ 81